Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Found vs PrescrYbe

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Found logo

Found

8.3
★★★★☆4.2/5

Best for: mainstream telehealth GLP-1 access

Visit Found →
VS

PrescrYbe

7.3
★★★★☆3.7/5

Best for: shoppers who want an oral GLP-1 option or a low-dose microdosing tier

Visit PrescrYbe →

Found and PrescrYbe are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Found starts lower at $169/mo versus $179/mo, and Found edges ahead overall (8.3 vs 7.3 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

Found

flat price at every doseCompounded
$169$99/mo
Save 41% right now
semaglutide

$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.

flat price at every doseCompounded
$169$99/mo
Save 41% right now
tirzepatide

Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.

StartingCompounded · oral
$149/mo
orforglipron (foundayo)

'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.

StartingBrand-name
$650/mo
semaglutide (wegovy)

Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.

StartingBrand-name
$650/mo
tirzepatide (zepbound)

Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.

StartingBrand-name
$1100/mo
semaglutide (ozempic)

Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.

StartingBrand-name
$1100/mo
tirzepatide (mounjaro)

Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.

PrescrYbe

Semaglutide injection (charged every 4 weeks)Compounded
$249/mo
semaglutide

Card reads "$249 per 4 week". A 4-week cycle is 13 charges a year, not 12 — the site states the cadence openly.

Tirzepatide injection (charged every 4 weeks)Compounded
$339/mo
tirzepatide

Card reads "$339 per 4 week".

Oral semaglutide, single-ingredient (charged every 4 weeks)Compounded
$279/mo
semaglutide

Card reads "$279 per 4 week" for the oral formulation.

Microdose semaglutide (charged every 4 weeks)Compounded
$179/mo
semaglutide

Low-dose tier, "$179 per 4 week".

Microdose tirzepatide (charged every 4 weeks)Compounded
$179/mo
tirzepatide

Low-dose tier, "$179 per 4 week".

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 510+ providers' prices on their own sites and email you when tracked prices move.

What’s included

Found

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Included

PrescrYbe

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Found

8.3/10

Overall

PrescrYbe

7.3/10

Value25%

8.5A
vs
B
7.5

Effectiveness25%

9.0A
vs
B
8.0

User Experience15%

8.0A
vs
B
7.5

Trust & Safety15%

7.3A
vs
B
6.0

Accessibility10%

8.5A
vs
B
7.5

Support10%

7.5A
vs
B
6.0

Features & Coverage

FeatureFoundPrescrYbe
Starting Price✓$169/mo$179/mo
Features3 features✓6 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA WarningsNoneNone

About Found

Personalized weight care platform with a self-pay membership model plus medication costs.

Read our full Found review →

About PrescrYbe

PrescrYbe is a cash-pay telehealth platform offering compounded semaglutide and tirzepatide as injections or an oral formulation, plus low-dose microdosing tiers from $179. Pricing is billed every 4 weeks rather than monthly and the cadence is stated on the product card. Consultations, medication and shipping are bundled into one price, and you are not charged if a provider finds you ineligible.

Read our full PrescrYbe review →

Pros & Cons

Found

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

PrescrYbe

What we like

  • Five GLP-1 tiers including an oral semaglutide option and $179 microdosing for both drugs
  • Billing cadence is printed on the product card — most sites hide the 4-week cycle
  • Price shown before you start intake, not after
  • Consultation, medication and shipping bundled into one cash-pay price
  • Full refund if a provider finds you ineligible: "If you don't qualify, you don't pay"

Watch-outs

  • Charged every 4 weeks, so a year costs 13 payments, not 12 — $3,237/yr on semaglutide, not $2,988
  • Neither the prescribing medical group nor the pharmacy partner is named anywhere in the terms
  • No published state list — terms say only that some services may not be available in all states
  • Cancellation is by email to care@prescrybe.health; no self-serve cancel is documented
  • No support phone number published
  • Compounded only, and the terms confirm compounded drugs are not FDA approved

Our Verdict

Winner: Found

Found edges out PrescrYbe with a higher overall score of 8.3/10 and is particularly strong for mainstream telehealth GLP-1 access. PrescrYbe remains a solid alternative, especially if you're looking for shoppers who want an oral GLP-1 option or a low-dose microdosing tier.

Choose Found if…

You want mainstream telehealth GLP-1 access and a starting price around $169/mo.

Choose PrescrYbe if…

You want shoppers who want an oral GLP-1 option or a low-dose microdosing tier and a starting price around $179/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.0

Strut Health

Oral-lozenge compounded GLP-1 access

7.8

Yucca Health

Mainstream telehealth GLP-1 access

7.7

TrimRx

Best overall value

Found vs PrescrYbe: FAQ

Found is cheaper. Its lowest ongoing monthly cash price is $169/mo, compared with $179/mo for PrescrYbe. We compare standing (not first-month promo) prices so the figures reflect what you'd actually pay month to month.
Found scores higher overall at 8.3/10 versus 7.3/10, and is particularly strong for mainstream telehealth GLP-1 access. That said, PrescrYbe is a better fit if you want shoppers who want an oral GLP-1 option or a low-dose microdosing tier.
Found lists availability in 50 states, while PrescrYbe's state list is not publicly listed.
Found is an affiliate partner (we may earn a commission on sign-ups through our links); PrescrYbe is not. Either way, we rank providers editorially with the same scoring framework and disclose every partnership — being a partner does not buy a higher score.
For Semaglutide, Found is cheaper at $99/mo versus $179/mo at PrescrYbe.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring Found and PrescrYbe head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.